Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v5-FR
Language English French
Date Updated 2020-09-10 2020-07-28
Drug Identification Number 02232570 02232570
Brand name AIROMIR AIROMIR
Common or Proper name AIROMIR AIROMIR
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients SALBUTAMOL SALBUTAMOL
Strength(s) 100MCG 100MCG
Dosage form(s) METERED-DOSE AEROSOL METERED-DOSE AEROSOL
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 200 dose 200 dose
ATC code R03AC R03AC
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-08-31 2020-08-17
Actual start date
Estimated end date 2020-10-15
Actual end date 2020-09-07
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments